Bayer missed analysts' sales expectations and was punished with -6%.
I have a small Bayer position in the portfolio, and am currently considering whether to use this dip. Bayer convinces me with its broad product range from pharmaceuticals to agricultural products. A thorn in my side is the debt and the ongoing lawsuits. The lawsuits cost the company a lot of money and damage its reputation. Nevertheless, I have to say that $BAYN benefits from the #monsanto acquisition benefits. Besides $ADM and $BAS Bayer is a top dog in genetically modified agricultural products.
Conclusion: I need to take a closer look at the company and then weigh up